Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Hydroxyurea + MU380 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Hydroxyurea | Droxia | Carbamohydroxamic Acid|Hydroxycarbamide | Droxia (hydroxyurea) inhibits ribonucleoside diphosphate reductase, resulting in cell cycle arrest (NCI Drug Dictionary). | |
MU380 | CHK1 Inhibitor 18 | MU380 is a selective inhibitor of CHK1, which increases sensitivity of tumor cells to DNA damaging agents, potentially resulting in decreased tumor growth (PMID: 28619751, PMID: 30975914, PMID: 32579780). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|